1-7 of 7
Marco Sorio
Close
Sort by
Journal Articles

Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma

Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi, Andrea Rossi, Alessandra Romano, Caterina Patti, Corrado Schiavotto, Roberto Sorasio, Vincenzo Marasco, Laura Lissandrini, Davide Rapezzi, Daniela Gottardi, Federica Cocito, Antonio Mulé, Salvatore Leotta, Guido Gini, Marco Sorio, Enrico Derenzini, Alessandro Rambaldi, Corrado Tarella, Vincenzo Bagnardi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6179.
https://doi.org/10.1182/blood-2023-173085
Published: 2023
Journal Articles

Male Gender, Quality of Grafted Cells, Advanced Age, Rituximab and Radiotherapy Are the Main Factors That Variously Influence the Occurrence of Secondary Malignancies Following High-Dose Therapy and Autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Survey in 1,347 Lymphoma Patients.

Corrado Tarella, MD, Roberto Passera, PhD, Michele Magni, MD, Andrea Rossi, MD, Fabio Benedetti, MD, Angela Gueli, Jr., MD, Caterina Patti, MD, Guido Parvis, MD, Fabio Ciceri, MD, Andrea Gallamini, MD, Sergio Cortelazzo, MD, Paolo Corradini, MD, Valerio Zoli, MD, Antonio Mule', MD, Roberto Crocchiolo, MD, Marco Bosa, MD, Anna Barbui, MD, Massimo Di Nicola, MD, Daniele Caracciolo, MD, Marco Sorio, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2009) 114 (22): 519.
https://doi.org/10.1182/blood.V114.22.519.519
Published: 2009
Journal Articles

High-Dose Sequential Chemotherapy (HDS) Followed by Autologous Stem Cell Transplantation (ASCT) in Relapsing/Refractory Hodgkin Lymphoma (HL): Long-Term Results.

Andrea Gallamini, Claudia Castellino, Simonetta Viviani, Andrea Rossi, Atto Billio, Alessandro Mistretta, Marco Sorio, Angela Gueli, Alessandro Rambaldi, Sergio Cortelazzo, Caterina Patti, Fabio Benedetti, PierFederico Torchio, Alessandro M. Gianni, Corrado Tarella
Journal: Blood
Blood (2007) 110 (11): 5118.
https://doi.org/10.1182/blood.V110.11.5118.5118
Published: 2007
Journal Articles

Prolonged Survival of Lymphoma Patients Achieving Complete Remission Following High-Dose Sequential Chemotherapy and Autograft (HDS Program): A GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) Retrospective Study on 1,266 Patients.

Corrado Tarella, Manuela Zanni, Alessandro Rambaldi, Michele Magni, Marco Sorio, Roberto Passera, Caterina Patti, Fabio Ciceri, Andrea Gallamini, Sergio Cortelazzo, Ignazio Majolino, Salvatore Mirto, Mario Boccadoro, Paolo Corradini, Fabio Benedetti, Tiziano Barbui, Alessandro M. Gianni
Journal: Blood
Blood (2006) 108 (11): 3046.
https://doi.org/10.1182/blood.V108.11.3046.3046
Published: 2006
Journal Articles

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.

Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Marco Sorio, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Atto Billio, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD, Sergio Cortelazzo, MD
Journal: Blood
Blood (2006) 108 (11): 2744.
https://doi.org/10.1182/blood.V108.11.2744.2744
Published: 2006
Journal Articles

Imatinib Therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem Cell Transplantation: A Molecular Analysis.

Francesca Palandri, Giovanni Martinelli, Marilina Amabile, Francesca Bonifazi, Giuseppe Bandini, Fabio Benedetti, Emilio Usala, Emanuele Angelucci, Mario Tiribelli, Renato Fanin, Marco Sorio, Mario Arpinati, Nicoletta Testoni, Sadia Falcioni, Maria Benedetta Giannini, Angela Poerio, Simona Soverini, Fabrizio Pane, Gianantonio Rosti, Sante Tura, Michele Baccarani
Journal: Blood
Blood (2004) 104 (11): 4655.
https://doi.org/10.1182/blood.V104.11.4655.4655
Published: 2004
Journal Articles

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Clinical Trials & Observations
Marco Ladetto, Paolo Corradini, Sonia Vallet, Fabio Benedetti, Umberto Vitolo, Maurizio Martelli, Maura Brugiatelli, Paolo Coser, Alessio Perrotti, Ignazio Majolino, Giuseppe Fioritoni, Sergio Morandi, Maurizio Musso, Renato Zambello, Teodoro Chisesi, Nicola Di Renzo, Paolo Vivaldi, Alberto De Crescenzo, Andrea Gallamini, Flavia Salvi, Gino Santini, Carola Boccomini, Marco Sorio, Monica Astolfi, Daniela Drandi, Alessandro Pileri, Corrado Tarella
Journal: Blood
Blood (2002) 100 (5): 1559–1565.
https://doi.org/10.1182/blood-2002-02-0621
Published: 2002